Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit

NCT02804854 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Lung Disease

Interventions

DRUG: Neutrophil Activation Probe (NAP)

Sponsor

University of Edinburgh

Collaborators

[object Object]